Hinge Health, Inc. (HNGE)
NYSE: HNGE · Real-Time Price · USD
45.78
-2.15 (-4.49%)
Jul 15, 2025, 4:00 PM - Market closed
Hinge Health Market Cap
Hinge Health has a market cap or net worth of $3.57 billion as of July 16, 2025.
Market Cap
3.57B
Enterprise Value
3.11B
1-Year Change
n/a
Ranking
Category
Stock Price
45.78
Market Cap Chart
Since the IPO on May 22, 2025, Hinge Health's market cap has increased from $2.58B to $3.57B, an increase of 38.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2025 | 3.74B | 0.61% |
| Jul 11, 2025 | 3.72B | 7.93% |
| Jul 10, 2025 | 3.44B | -1.52% |
| Jul 9, 2025 | 3.50B | 3.97% |
| Jul 8, 2025 | 3.36B | 0.09% |
| Jul 7, 2025 | 3.36B | -7.63% |
| Jul 3, 2025 | 3.64B | 4.53% |
| Jul 2, 2025 | 3.48B | -1.54% |
| Jul 1, 2025 | 3.53B | -12.44% |
| Jun 30, 2025 | 4.04B | 11.27% |
| Jun 27, 2025 | 3.63B | 3.45% |
| Jun 26, 2025 | 3.51B | 0.97% |
| Jun 25, 2025 | 3.47B | -5.09% |
| Jun 24, 2025 | 3.66B | 7.39% |
| Jun 23, 2025 | 3.41B | 3.85% |
| Jun 20, 2025 | 3.28B | 5.89% |
| Jun 18, 2025 | 3.10B | 4.55% |
| Jun 17, 2025 | 2.96B | 4.94% |
| Jun 16, 2025 | 2.82B | 3.90% |
| Jun 13, 2025 | 2.72B | -0.49% |
| Jun 12, 2025 | 2.73B | -0.40% |
| Jun 11, 2025 | 2.74B | -3.91% |
| Jun 10, 2025 | 2.85B | -3.71% |
| Jun 9, 2025 | 2.96B | -2.29% |
| Jun 6, 2025 | 3.03B | 1.01% |
| Jun 5, 2025 | 3.00B | -3.77% |
| Jun 4, 2025 | 3.12B | -0.82% |
| Jun 3, 2025 | 3.15B | -0.27% |
| Jun 2, 2025 | 3.16B | 4.15% |
| May 30, 2025 | 3.03B | -0.82% |
| May 29, 2025 | 3.06B | -4.49% |
| May 28, 2025 | 3.20B | -2.68% |
| May 27, 2025 | 3.29B | 4.91% |
| May 23, 2025 | 3.13B | 21.49% |
| May 22, 2025 | 2.58B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.91B |
| Johnson & Johnson | 377.51B |
| AbbVie | 339.94B |
| Novo Nordisk | 305.41B |
| UnitedHealth Group | 275.86B |
| Novartis AG | 236.71B |
| Abbott Laboratories | 229.69B |
| AstraZeneca | 218.74B |